- Home
- NNOX vs XOMA Comparison
NNOX vs XOMA Comparison
Compare NNOX & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNOX
- XOMA
- Stock Information
- Founded
- NNOX 2011
- XOMA 1981
- Country
- NNOX Israel
- XOMA United States
- Employees
- NNOX N/A
- XOMA N/A
- Industry
- NNOX Medical Electronics
- XOMA Biotechnology: Pharmaceutical Preparations
- Sector
- NNOX Health Care
- XOMA Health Care
- Exchange
- NNOX Nasdaq
- XOMA Nasdaq
- Market Cap
- NNOX 304.8M
- XOMA 250.1M
- IPO Year
- NNOX 2020
- XOMA N/A
- Fundamental
- Price
- NNOX $5.20
- XOMA $21.18
- Analyst Decision
- NNOX Strong Buy
- XOMA Strong Buy
- Analyst Count
- NNOX 2
- XOMA 3
- Target Price
- NNOX $12.00
- XOMA $59.67
- AVG Volume (30 Days)
- NNOX 1.5M
- XOMA 26.2K
- Earning Date
- NNOX 05-27-2025
- XOMA 05-08-2025
- Dividend Yield
- NNOX N/A
- XOMA N/A
- EPS Growth
- NNOX N/A
- XOMA N/A
- EPS
- NNOX N/A
- XOMA N/A
- Revenue
- NNOX $11,283,000.00
- XOMA $28,487,000.00
- Revenue This Year
- NNOX $156.75
- XOMA $14.22
- Revenue Next Year
- NNOX $180.02
- XOMA $34.01
- P/E Ratio
- NNOX N/A
- XOMA N/A
- Revenue Growth
- NNOX 13.91
- XOMA 498.72
- 52 Week Low
- NNOX $3.75
- XOMA $18.35
- 52 Week High
- NNOX $11.00
- XOMA $35.00
- Technical
- Relative Strength Index (RSI)
- NNOX 51.23
- XOMA 54.26
- Support Level
- NNOX $4.40
- XOMA $20.00
- Resistance Level
- NNOX $4.84
- XOMA $21.55
- Average True Range (ATR)
- NNOX 0.41
- XOMA 1.20
- MACD
- NNOX 0.08
- XOMA 0.29
- Stochastic Oscillator
- NNOX 93.55
- XOMA 79.27
About NNOX NANO-X IMAGING LTD
Nano X Imaging Ltd is engaged in the business of manufacturing medical imaging systems. It offers a Nanox System which is a combination of hardware and software. It develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service.
About XOMA XOMA Corporation
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.